| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Feb―22 |
The interplay of tuberculosis and COVID-19: Insights into global health challenges |
Kirtimaan Syal |
| 2 |
[GO] |
2023―Dez―08 |
SARS-CoV-2 testing and its role in understanding the evolving landscape of the pandemic in Bangladesh |
Shafiul Azam, Mohammed Sayem, Salim Khan, Catherine Martini, Murshed Hasan Sarkar, Shahina Akter, et al. (+3) Barna Goswami, Sylvana Q Sinha, Zaheed Husain |
| 3 |
[GO] |
2021―Dez―01 |
COVID-19 variants that escape vaccine immunity: Global and Indian context-are more vaccines needed? |
Bijayeeta Deb, Ramya Vilvadrinath, Suchi Goel |
| 4 |
[GO] |
2021―Nov―25 |
Central nervous system as a target of novel coronavirus infections: Potential routes of entry and pathogenic mechanisms |
Sapana Sharma, Harsha Jagadeesh, Ambrish Saxena, Harshini Chakravarthy, Vasudharani Devanathan |
| 5 |
[GO] |
2021―Nov―16 |
Why are some coronavirus variants more infectious? |
Raju Mukherjee, Rohit Satardekar |
| 6 |
[GO] |
2021―Okt―30 |
Temporal stability and detection sensitivity of the dry swab-based diagnosis of SARS-CoV-2 |
C G Gokulan, Uday Kiran, Santosh Kumar Kuncha, Rakesh K Mishra |
| 7 |
[GO] |
2021―Mai―27 |
COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation |
Sutapa Som Chaudhury, Koel Sinha, Rabindranath Majumder, Atanu Biswas, Chitrangada Das Mukhopadhyay |
| 8 |
[GO] |
2021―Feb―20 |
SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants |
Surabhi Srivastava, Sofia Banu, Priya Singh, Divya Tej Sowpati, Rakesh K. Mishra |
| 9 |
[GO] |
2021―Feb―03 |
Pattern of genomic variation in SARS-CoV-2 (COVID-19) suggests restricted nonrandom changes: Analysis using Shewhart control charts |
SAURAV MANDAL, TANMOY ROYCHOWDHURY, ALOK BHATTACHARYA |
| 10 |
[GO] |
2020―Nov―24 |
COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development |
M Sreepadmanabh, Amit Kumar Sahu, Ajit Chande |
| 11 |
[GO] |
2020―Okt―16 |
Identification of a repurposed drug as an inhibitor of Spike protein of human coronavirus SARS-CoV-2 by computational methods |
Sruthi Unni, Snehal Aouti, Saravanamuthu Thiyagarajan, Balasundaram Padmanabhan |
| 12 |
[GO] |
2020―Jul―17 |
Computational search for potential COVID-19 drugs from FDA-approved drugs and small molecules of natural origin identifies several anti-virals and plant products |
Abhishek Sharma, Vikas Tiwari, Ramanathan Sowdhamini |
| 13 |
[GO] |
2020―Jul―16 |
RNAi suppressor: The hidden weapon of SARS-CoV |
Sumona Karjee, Sunil Kumar Mukherjee |
| 14 |
[GO] |
2020―Jun―29 |
Drug targets for COVID-19 therapeutics: Ongoing global efforts |
Ambrish Saxena |
| 15 |
[GO] |
2020―Jun―12 |
Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials |
Bijayeeta Deb, Hemal Shah, Suchi Goel |
| 16 |
[GO] |
2020―Jun―04 |
Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility |
Arindam Maitra, Mamta Chawla Sarkar, Harsha Raheja, Nidhan K Biswas, Sohini Chakraborti, Animesh Kumar Singh, et al. (+12) Shekhar Ghosh, Sumanta Sarkar, Subrata Patra, Rajiv Kumar Mondal, Trinath Ghosh, Ananya Chatterjee, Hasina Banu, Agniva Majumdar, Sreedhar Chinnaswamy, Narayanaswamy Srinivasan, Shanta Dutta, Saumitra Das |
| 17 |
[GO] |
2020―Mai―07 |
Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus |
Raju Mukherjee |
